Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic Effect of Intrathecal Clonidine in Hypertensive Subjects
NCT01297335Phase 2Completed
- Sponsor
- Center for Clinical Research
- Start
- Feb 2011
- Primary completion
- Jul 2012
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of clonidine in hypertension (HTN), sponsored by Center for Clinical Research. Primary endpoint: Change in Blood Pressure After Intrathecal Injection of Clonidine at 240 months. Started Feb 2011; status: completed.
02
Drugs
clonidine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01297335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01297335.